De-Hwa Chao

Title: **Inventor Spotlight: De-Hwa Chao**

Introduction

De-Hwa Chao is a notable inventor based in Cupertino, California, recognized for his contributions to the pharmaceutical field through innovative formulations. With a focus on micronized opioid compositions, he has developed technologies that aim to improve the efficacy and safety of opioid medications.

Latest Patents

Chao holds a patent for "Micronized opioid compositions having a specific particle size distribution." This innovative patent describes novel compositions, formulations, and dosage forms that include stabilized micronized opioid particles. The compositions can feature opioids such as oxycodone, oxymorphone, hydrocodone, and hydromorphone, whether in free base form or as salts. Specifically, the patent discloses stabilized micronized opioid particles with a Dv90 particle size distribution of 10 micrometers or less, or alternatively, 20 micrometers or less. The patent also encompasses methods for micronizing opioids to achieve these stabilized forms, enhancing their delivery and effectiveness.

Career Highlights

Throughout his career, De-Hwa Chao has demonstrated a commitment to advancing pharmaceutical innovation. His work in creating stabilized micronized opioid particles highlights his focus on addressing the challenges faced in opioid delivery systems, thereby improving patient outcomes.

Collaborations

Chao has collaborated with several talented colleagues, including Michael S. Zamloot and Cherng-Chyi Fu, who have contributed their expertise to further enhance the innovation and application of his patented technologies.

Conclusion

De-Hwa Chao exemplifies the pioneering spirit of inventors in the pharmaceutical industry. Through his patented innovations, he continues to impact the way opioids are formulated and delivered, striving to improve safety and efficacy for patients in need. His work reflects the ongoing evolution of medical solutions that can change lives for the better.